A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major adverse cardiovascular event (MACE) (the composite of cardiovascular \[CV\] death, myocardial infarction \[MI\], and ischemic stroke).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (1003)
| Advanced Cardiovascular, LLC | Alexander City, Alabama, United States | — |
| SORRA Research | Birmingham, Alabama, United States | — |
| Ascension St. Vincent's Health System | Birmingham, Alabama, United States | — |
| IMC-Diagnostic and Medical Clinic | Mobile, Alabama, United States | — |
| Cardiology Associates of Mobile Inc | Mobile, Alabama, United States | — |
| Mercy Gilbert Medical Center | Gilbert, Arizona, United States | — |
| Valleywise Health Medical Center | Phoenix, Arizona, United States | — |
| HonorHealth Neurology | Scottsdale, Arizona, United States | — |
| Arkansas Heart Hospital | Little Rock, Arkansas, United States | — |
| Bakersfield Memorial Hospital | Bakersfield, California, United States | — |
| Mission Cardiovascular Research Institute | Fremont, California, United States | — |
| Radin Cardiovascular Medical Group | Newport Beach, California, United States | — |
+ 991 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05754957